In the fourth part of our investigation into the Miracle Biologic Lecanemab, we disclosed that the US based Alzheimer’s Association received over $750,000 from Eisai in 2023.
Writing in the Guardian, Margaret McCartney highlighted that doctors seldom truly comprehend the extent of industry influence.
‘Data published by the Association of the British Phar…
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.